Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%
MUMBAI, India and MAHWAH, N.J., Aug. 17, 2023 /PRNewswire/ — Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, integrated, global pharmaceutical company
Read More